Clincosm LogoSign in Get a demo

acute lymphoblastic leukemia, pediatric

Showing 1 - 20 of 20
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Parental Perception of Their Child's Emotional Quality of Life

Not yet recruiting
  • Acute Lymphoblastic Leukemia, Pediatric
  • Self-report questionnaires (only for parents)
  • +2 more
  • (no location specified)
Oct 24, 2023

Acute Lymphoblastic Leukemia, Pediatric Trial (CareMeds Intervention, Usual Care Group)

Not yet recruiting
  • Acute Lymphoblastic Leukemia, Pediatric
  • CareMeds Intervention
  • Usual Care Group
  • (no location specified)
Oct 12, 2023

Acute Lymphoblastic Leukemia, Pediatric Trial in Bratislava (Lacticaseibacillus paracasei subsp. Paracasei CNCMI-1518, Physical

Recruiting
  • Acute Lymphoblastic Leukemia, Pediatric
  • Lacticaseibacillus paracasei subsp. Paracasei CNCMI-1518
  • Physical exercise
  • Bratislava, Slovakia
    Department of Pediatric Hematology National Institute of Childre
Jul 12, 2023

Next-generation Sequencing in Pediatric B-ALL Children Patients

Not yet recruiting
  • Acute Lymphoblastic Leukemia, Pediatric
  • (no location specified)
Apr 19, 2023

Determining the Mechanisms of Loss of CAR T Cell Persistence

Not yet recruiting
  • Acute Lymphoblastic Leukemia With Failed Remission
  • +4 more
    • (no location specified)
    Mar 29, 2023

    Vaccine Immune Recovery After Leukemia

    Enrolling by invitation
    • Acute Lymphoblastic Leukemia, Pediatric
    • Observational only
    • Chicago, Illinois
    • +2 more
    Nov 9, 2022

    Acute Lymphoblastic Leukemia, Pediatric Trial in Canada, United States (Pegaspargase, Erwinia asparaginase, Cyclophosphamide)

    Active, not recruiting
    • Acute Lymphoblastic Leukemia, Pediatric
    • Boston, Massachusetts
    • +8 more
    Nov 10, 2022

    Acute Lymphoblastic Leukemia, Pediatric Trial in Worldwide (Blinatumomab, Bortezomib, Cyclophosphamide)

    Recruiting
    • Acute Lymphoblastic Leukemia, Pediatric
    • Sydney, Australia
    • +114 more
    Nov 1, 2022

    Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphoblastic Leukemia With Failed Remission, Acute Lymphoblastic Leukemia

    Recruiting
    • Acute Lymphoblastic Leukemia, in Relapse
    • +5 more
    • CAR-20/19-T cells (1 x 10^5 CAR-20/19-T cells/kg)
    • +4 more
    • Milwaukee, Wisconsin
      Medical College of Wisconsin
    Sep 22, 2022

    B Cell Lymphoma, Acute Lymphoblastic Leukemia, Pediatric, Lymphoma Trial in Stanford (Fludarabine, Cyclophosphamide, Autologous

    Suspended
    • B Cell Lymphoma
    • +2 more
    • Stanford, California
      Stanford Medical Center
    Sep 8, 2022

    Pediatric Acute Lymphoblastic Leukemia

    Enrolling by invitation
    • Acute Lymphoblastic Leukemia, Pediatric
    • Adverse Drug Event
      • Stanford, California
        Stanford University
      Mar 7, 2022

      Acute Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia, Adult, Acute Lymphoblastic Leukemia, Pediatric Trial in Denmark,

      Recruiting
      • Acute Lymphoblastic Leukemia
      • +4 more
      • Copenhagen, Denmark
      • +16 more
      Jan 26, 2022

      Healthy Bones, Healthy Life

      Recruiting
      • Acute Lymphoblastic Leukemia, Pediatric
      • +12 more
        • Omaha, Nebraska
          University of Nebraska Medical Center
        Dec 10, 2021

        Acute Lymphoblastic Leukemia, Pediatric Trial in Giza (Balance exrcises, Balance exrcises and Treadmill training)

        Completed
        • Acute Lymphoblastic Leukemia, Pediatric
        • Balance exrcises
        • Balance exrcises and Treadmill training
        • Giza, Cairo, Egypt
        • +1 more
        Nov 12, 2021

        Acute Lymphoblastic Leukemia, Pediatric, Relapsed Acute Lymphoblastic Leukemia, Refractory Acute Lymphoblastic Leukemia Trial in

        Recruiting
        • Acute Lymphoblastic Leukemia, Pediatric
        • +2 more
        • Stanford, California
          Lucile Packard Children's Hospital Stanford
        Sep 20, 2021

        Acute Lymphoblastic Leukemia, Pediatric Trial in Cairo (Curcumin, Standard of Care)

        Recruiting
        • Acute Lymphoblastic Leukemia, Pediatric
        • Cairo, Non-US, Egypt
          Pediatric Hematology Oncology and BMT Unit, Faculty of Medicine
        Sep 16, 2021

        Acute Lymphoblastic Leukemia, Pediatric, ALL, Infants Trial (the risk-adapted choice of therapy and the use of a combination of

        Not yet recruiting
        • Acute Lymphoblastic Leukemia, Pediatric
        • ALL, Infants
        • the risk-adapted choice of therapy and the use of a combination of chemotherapy with immunotherapy and hematopoietic stem cell transplantation for patients with risk factors.
        • (no location specified)
        Aug 26, 2021

        Acute Lymphoblastic Leukemia, Pediatric Trial in Tanjin (6-mercaptopurine, Standard treatment, Individualized treatment)

        Not yet recruiting
        • Acute Lymphoblastic Leukemia, Pediatric
        • Tanjin, Tianjin, China
          State Key Laboratory of Experimental Haematology, Department of
        Jan 10, 2020

        Acute Lymphoblastic Leukemia, Pediatric, Obesity, Pediatric Trial in United States (Low Glycemic Index Diet)

        Unknown status
        • Acute Lymphoblastic Leukemia, Pediatric
        • Obesity, Pediatric
        • Low Glycemic Index Diet
        • Hartford, Connecticut
        • +4 more
        Jun 10, 2019

        Intermediate Metabolism in Acute Lymphoblastic Leukemia (ALL)

        Unknown status
        • Acute Lymphoblastic Leukemia, Pediatric
        • Metabolism Disorder
        • Metabolome study
        • Thessaloniki, Greece
          Aristotle University of Thessaloniki
        Jan 26, 2017